| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/04/2004 | US20040043405 Used in the diagnosis of disease, in quality control in evaluating external data or databases, and in normalization of external data for comparative purposes; used to produce microarrays that generate data with improved reliability |
| 03/04/2004 | US20040043404 A chemical moiety that prohibits recrystallization of a denatured DNAportion |
| 03/04/2004 | US20040043403 Use of transcription or translation products of genes the expression levels of which correlate with the biological activity of an EGFR tyrosine kinase inhibitor |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043397 Identification and isolation of novel DNA and the recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein |
| 03/04/2004 | US20040043396 Recombinant terminal deoxynucleotidyl transferase with improved functionality |
| 03/04/2004 | US20040043395 Use of these sequences in the diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, and developmental disorders |
| 03/04/2004 | US20040043394 Arylhydrocarbon receptor (AhR) |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043390 Nucleotide sequences are used to store meaningful information, such as letters, words, phrases, signs, icons, musical notes, numbers or bits and bitmaps in any cultural context including languages, phonetics, multimedia applications, codes |
| 03/04/2004 | US20040043389 Abnormally low lipid levels such as low HDL-C levels, or a vascular or metabolic disease or disorder |
| 03/04/2004 | US20040043386 Methods and compositions for functional ubiquitin assays |
| 03/04/2004 | US20040043383 Method and probes for the detection of chromosome aberrations |
| 03/04/2004 | US20040043381 Multiple sclerosis associated retrovirus (MSRV) -1 ; long terminal repeat sequences (LTR) |
| 03/04/2004 | US20040043380 A T cell line carrying a reporter gene that contains an long terminal repeat (LTR) sequence of Human Immunodeficiency Virus (HIV); for use in an efficient screening method for efficiently finding out a medicine such as an anti-HIV agents |
| 03/04/2004 | US20040043379 Methods and probe-immobilized substrates for obtaining information regarding responsiveness to a treatment of a disease |
| 03/04/2004 | US20040043377 PM (poor metabolizers) |
| 03/04/2004 | US20040043376 Provides information on body fat loss and is usable by members of the general public on samples such as urine or saliva; disposable solid test strip capable of enabling a person to self-monitor fat loss on a daily basis |
| 03/04/2004 | US20040043116 Measuring time for amylase to hydrolyze labeled starch; calibration |
| 03/04/2004 | US20040043039 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsides |
| 03/04/2004 | US20040043023 Therapy, diagnosis of leukemia; detection of cancer lymphocytes in human |
| 03/04/2004 | US20040043021 Asthma therapy, diagnosis |
| 03/04/2004 | US20040042961 Using mutant green fluorescent protein |
| 03/04/2004 | US20040041089 Amino acid sequence pattern matching |
| 03/04/2004 | US20040040867 Method for the measurement of dithionite concentration |
| 03/04/2004 | US20040040866 Biosensor and measuring method using the same |
| 03/04/2004 | US20040040840 Controller for redox system |
| 03/04/2004 | US20040040839 Biosensor |
| 03/04/2004 | DE10238922A1 Immunmarker zur Diagnostik und Therapie im Zusammenhang mit Transplantat-Reaktionen Immune markers for diagnosis and treatment related to graft reactions |
| 03/04/2004 | DE10238630A1 Verfahren zur Isolierung biologischer Makromoleküle sowie Vorrichtung zur Durchführung dieses Verfahrens A method of isolating biological macromolecules, as well as apparatus for carrying out this method |
| 03/04/2004 | DE10238433A1 Verfahren zur Bestimmung des allelischen Zustandes des 5'-Ende des alpha-S1-Kaseingenes A method for determining the allelic state of the 5 'end of the alpha-S1-Kaseingenes |
| 03/04/2004 | DE10238046A1 Verfahren zum Untersuchen von Körperflüssigkeiten auf Krebszellen, dessen Verwendung, entsprechende Analysekits und Verwendung bestimmter Wirkstoffe zur Behandlung von Krebs A method for assaying body fluids for cancer cells, to its use, corresponding to the analysis kit and the use of certain compounds for the treatment of cancer |
| 03/04/2004 | DE10237691A1 Verfahren zum Nachweis von Einzelnukleotid-Polymorphismen (SNP) in Genen des Arzneimittelmetabolismus und Testkit zur Durchführung des Verfahrens A method for detecting single nucleotide polymorphisms (SNP) in genes of drug metabolism and test kit for performing the method |
| 03/04/2004 | DE10237284A1 Nukleinsäurenachweis Nucleic acid detection |
| 03/04/2004 | DE10235988A1 New mutant nucleic acid encoding the human MSH3 protein, useful e.g. for diagnosis and treatment of neoplasia, also for drug discovery |
| 03/04/2004 | DE10141464A1 New nucleic acid representing a polymorphism in the 22444 gene, useful for diagnosis and treatment of neuropsychiatric diseases and in drug screening |
| 03/04/2004 | DE10130155B3 Reportergen-Konstrukt zum Nachweis von HIV-Rev und HIV-Tat Reporter gene construct for the detection of HIV-Rev and HIV-Tat |
| 03/04/2004 | CA2746000A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745998A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745731A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745724A1 Biomarkers comprising peptide sequence vnhvtlsopk for diagnosing alzheimer's disease |
| 03/04/2004 | CA2745569A1 Biomarkers for diagnosing alzheimer`s disease |
| 03/04/2004 | CA2501719A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | CA2497107A1 Methods and compositions for categorizing patients |
| 03/04/2004 | CA2496781A1 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | CA2496572A1 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496483A1 Coded nucleic acid carriers |
| 03/04/2004 | CA2496472A1 High resolution analysis of genetic variation within cryptosporidium parvum |
| 03/04/2004 | CA2496429A1 Methods for diagnosing dementia-related neurological disorders |
| 03/04/2004 | CA2496321A1 Biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/04/2004 | CA2496268A1 Oligonucleotide tagged nucleoside triphosphates (otntps) for genetic analysis |
| 03/04/2004 | CA2496251A1 High-throughput assay of hematopoietic stem and progenitor cell proliferation |
| 03/04/2004 | CA2496234A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | CA2495794A1 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | CA2495546A1 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | CA2495425A1 Method for screening the allelic state at the 5'-flanking region of the alfasi casein gene |
| 03/04/2004 | CA2495208A1 Preservation of rna quality and content in tissue sections during immunohistochemistry |
| 03/04/2004 | CA2494993A1 Abasic site endonuclease assay |
| 03/04/2004 | CA2482031A1 Point source biological agent detection system |
| 03/03/2004 | EP1394544A1 Method for mixing ribonulceic acid in water insoluble media and application thereof |
| 03/03/2004 | EP1394542A1 Method of screening prion disease infection factor |
| 03/03/2004 | EP1394535A1 Rapid response glucose sensor |
| 03/03/2004 | EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease |
| 03/03/2004 | EP1394273A1 Diagnostic method and apparatus |
| 03/03/2004 | EP1394272A1 Method for detection of Ki-ras mutations |
| 03/03/2004 | EP1394271A1 Method for identifying nucleotide polymorphisms using resonance energy transfer |
| 03/03/2004 | EP1394270A2 Molecular constructs and methods of use for detection of biochemical reactions |
| 03/03/2004 | EP1394269A1 Method for the isolation of biological macromolecules and apparatus for conducting said method |
| 03/03/2004 | EP1394268A1 HNF1alpha as a tumor suppressor gene, and diagnostic and therapeutic applications thereof |
| 03/03/2004 | EP1394267A1 Single nucleotide polymorphisms predictive for cardiovascular disease, adverse drug reactions, and drug efficacy |
| 03/03/2004 | EP1394266A1 Detection of single nucleotide polymorphisms by single molecule analysis |
| 03/03/2004 | EP1394265A2 Method for the identification of fungizids using ribose 5-phosphate isomerase |
| 03/03/2004 | EP1394264A1 Casein soja peptone agar culture media for determining the presence of microorganisms in gaseous environment or on surfaces comprising hydrogen peroxide |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394173A1 Improved method for bisulfite treatment |
| 03/03/2004 | EP1394172A1 Improved method for bisulfite treatment |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393236A2 Method for analyzing t lymphocytes with the aid of t lymphocyte receptors of an organism |
| 03/03/2004 | EP1393075A2 Methods of screening and using inhibitors of angiogenesis |
| 03/03/2004 | EP1393074A1 Compositions and methods for the detection of biomarkers associated with cardiovascular disease |
| 03/03/2004 | EP1393067A1 Encapsulated cell indicator system |
| 03/03/2004 | EP1393039A2 Mutation induced optimization of receptor signal to noise ratio |
| 03/03/2004 | EP1393038A2 A quantitative hybridization assay for the analysis of nucleic acid |
| 03/03/2004 | EP1392872A2 Non-alloying core shell nanoparticles |
| 03/03/2004 | EP1392871A2 Molecular toxicology modeling |
| 03/03/2004 | EP1392870A1 Screening for enzyme inhibitors |
| 03/03/2004 | EP1392869A2 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error |
| 03/03/2004 | EP1392867A2 Antisense modulation of ptp1b expression |
| 03/03/2004 | EP1392864A2 Compositions and methods for gender sorting |
| 03/03/2004 | EP1392863A1 Method for determining the presence of extension products |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392860A1 Molecular detection chip including mosfet, molecular detection device employing the chip, and molecular detection method using the device |
| 03/03/2004 | EP1392858A2 Disease associated polymorphism in the ctla-4 locus |
| 03/03/2004 | EP1392857A2 Methods and compositions for identifying gene function |
| 03/03/2004 | EP1392856A2 Method for the simultaneous amplification of multiple sequences in a pcr reaction and marking thereof |
| 03/03/2004 | EP1392855A2 Methods and compositions for the diagnosis and treatment of viral disease using 55092 |
| 03/03/2004 | EP1392854A2 Dna chip for performing causal diagnosis of hypertension |